George V Papatheodoridis Selected Research

George V Papatheodoridis Research Topics

Disease

55	Chronic Hepatitis B 11/2022 - 07/2002
38	Fibrosis (Cirrhosis) 01/2022 - 02/2003
19	Liver Diseases (Liver Disease) 10/2022 - 07/2002
18	Infections 01/2022 - 07/2002
17	Hepatitis B 11/2022 - 03/2003
17	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2010
14	Non-alcoholic Fatty Liver Disease 10/2022 - 11/2006
14	Chronic Hepatitis C 05/2020 - 04/2006
6	Hepatitis 01/2019 - 04/2005
5	Neoplasms (Cancer) 01/2022 - 04/2007
5	Hepatitis D 01/2022 - 01/2014
4	Viremia 11/2008 - 07/2002
3	Coinfection 01/2021 - 11/2014
3	Weight Loss (Weight Reduction) 01/2018 - 02/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2013 - 11/2006
2	Hepatitis E 01/2022 - 07/2005
2	Inflammation (Inflammations) 11/2021 - 11/2006
2	Hematologic Diseases (Blood Diseases) 07/2018 - 01/2017
2	Overweight 01/2018 - 10/2016
2	Insulin Resistance 03/2017 - 12/2007
2	Hepatitis C 02/2017 - 01/2017
2	Chronic Renal Insufficiency 02/2017 - 11/2013
2	Alcoholic Fatty Liver 01/2017 - 01/2008
2	Fatty Liver 01/2017 - 04/2010
2	Alcoholism (Alcohol Abuse) 11/2014 - 04/2007
2	Virus Diseases (Viral Diseases) 12/2013 - 03/2008
2	Sclerosing Cholangitis 02/2008 - 04/2007
2	Peptic Ulcer (Peptic Ulcers) 02/2006 - 05/2004
2	Hemorrhage 02/2006 - 05/2004
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2003 - 08/2002
1	Chronic Disease (Chronic Diseases) 10/2022
1	Fatigue 10/2022
1	End Stage Liver Disease 09/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019

Drug/Important Bio-Agent (IBA)

38	Hepatitis B e AntigensIBA 11/2022 - 07/2002
32	Antiviral Agents (Antivirals)IBA 11/2022 - 07/2002
19	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 10/2003
18	Tenofovir (Viread)FDA Link 01/2022 - 12/2008
18	entecavir FDA Link 01/2022 - 03/2008
15	Lamivudine (Epivir)FDA Link 01/2017 - 07/2002
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
11	InterferonsIBA 01/2021 - 07/2005
9	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 03/2008
8	RNA (Ribonucleic Acid)IBA 11/2022 - 08/2010
7	AntigensIBA 11/2022 - 10/2003
7	nasIBA 01/2021 - 02/2013
7	Alanine Transaminase (SGPT)IBA 01/2018 - 04/2007
5	EnzymesIBA 01/2022 - 05/2004
5	Pharmaceutical PreparationsIBA 01/2017 - 08/2004
5	adefovirIBA 11/2011 - 01/2003
4	AdipokinesIBA 01/2009 - 11/2006
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 03/2003
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 11/2018
3	Transaminases (Aminotransferases)IBA 01/2019 - 12/2008
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018 - 04/2007
3	AdiponectinIBA 03/2017 - 11/2006
3	Ribavirin (Virazole)FDA LinkGeneric 04/2016 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2008
3	Immunoglobulin M (IgM)IBA 01/2014 - 10/2003
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2013 - 04/2006
3	adefovir dipivoxil (Hepsera)FDA Link 01/2011 - 08/2004
3	NucleosidesIBA 08/2006 - 07/2002
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2014
2	hepatitis B hyperimmune globulinIBA 01/2021 - 03/2003
2	Rituximab (Mabthera)FDA Link 07/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 01/2012
2	Triglycerides (Triacylglycerol)IBA 03/2017 - 01/2012
2	SofosbuvirIBA 02/2017 - 01/2014
2	NucleotidesIBA 12/2013 - 08/2006
2	CreatinineIBA 11/2011 - 05/2005
2	Keratin-18 (Keratin 18)IBA 01/2011 - 04/2010
2	Telbivudine FDA Link 12/2008 - 03/2008
2	LeptinIBA 01/2008 - 11/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2006 - 05/2004
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 12/2003 - 08/2002
1	ethyl 4-chloro-3-hydroxybutanoate (CHBE)IBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 11/2021
1	QuercetinIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Dietary Fats (Dietary Fat)IBA 11/2021
1	FlavonoidsIBA 11/2021
1	Galectin 3 (LGALS3)IBA 09/2021
1	SodiumIBA 09/2021
1	Cytidine Triphosphate (CTP)IBA 09/2021
1	AlbuminsIBA 06/2021
1	AutoantibodiesIBA 01/2019
1	Azathioprine (Imuran)FDA LinkGeneric 01/2019

Therapy/Procedure

52	Therapeutics 11/2022 - 07/2002
11	Liver Transplantation 01/2022 - 03/2003
3	Aftercare (After-Treatment) 01/2022 - 04/2016
3	Retreatment 01/2020 - 01/2018
3	Contraindications 02/2017 - 11/2010
3	Transplantation 07/2005 - 03/2003
2	Kidney Transplantation 02/2017 - 11/2013
1	Precision Medicine 12/2020